Document is current
Any future updates will be listed below
-
Authors
Lv, Xiangmin
Liu, Jiyuan https://orcid.org/0000-0002-0372-4106
Islam, Kazi
Ruan, Jinpeng
He, Chunbo
Chen, Peichao
Huang, Cong
Wang, Hongbo
Dhar, Anjali
Moness, Madelyn
Shi, Davie https://orcid.org/0009-0003-0498-6321
Murphy, Savannah
Zhao, Xingeng
Yang, Siyi
Montoute, Isabelle
Polakkattil, Aneeta
Chung, Andie
Ruiz, Emily
Carbajal, Brianna
Padavala, Alekhya
Chen, Li
Hua, Guohua
Chen, Xingcheng
Davis, John S. https://orcid.org/0000-0003-3468-4079
Wang, Cheng https://orcid.org/0000-0002-0911-8254
- License Information
-
More Information
Article History
Received: 19 May 2024
Revised: 12 February 2025
Accepted: 17 March 2025
First Online: 10 April 2025
Competing interests
: The authors declare no competing interests.
: Xenograft tumor mouse models were generated and used to examine the role of hyperactivated YAP1 oncoprotein in ccRCC progression. Mouse handling and all experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Nebraska Medical Center (UNMC) and Massachusetts General Hospital (MGH). No human subjects were involved in this study.
